Evidence map›Paper›PMID 38542626›Full record

ArticleMicromachines2024

Chitosan as an Alternative to Oil-Based Materials for the Fabrication of Lab-on-a-Chip.

Morgane Zimmer, Stéphane Trombotto, Emmanuelle Laurenceau, Anne-Laure Deman

Abstract read
In one paragraph

Article in Micromachines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Morgane ZimmerEcole Centrale de Lyon, INSA Lyon, CNRS, Université Claude Bernard Lyon 1, CPE Lyon, INL, UMR5270, 69130 Ecully, France.ORCID 0009-0000-2307-9792
Stéphane TrombottoIngénierie des Matériaux Polymères (UMR5223), Université Claude Bernard Lyon 1, CNRS, INSA Lyon, Université Jean Monnet, 69622 Villeurbanne, France.ORCID 0000-0002-7750-2645
Emmanuelle LaurenceauEcole Centrale de Lyon, INSA Lyon, CNRS, Université Claude Bernard Lyon 1, CPE Lyon, INL, UMR5270, 69130 Ecully, France.ORCID 0000-0001-9601-7306
Anne-Laure DemanEcole Centrale de Lyon, INSA Lyon, CNRS, Université Claude Bernard Lyon 1, CPE Lyon, INL, UMR5270, 69130 Ecully, France.ORCID 0000-0001-9351-8703

Funding

Labex iMUST AGDI_246026_01
6 · The paper itself

Abstract

Given the growing importance of lab-on-a-chip in a number of fields, such as medical diagnosis or environmental analysis, the fact that the current fabrication process relies mainly on oil-based polymers raises an ecological concern. As an eco-responsible alternative, we presented, in this article, a manufacturing process for microfluidic devices from chitosan, a bio-sourced, biodegradable, and biocompatible polysaccharide. From chitosan powder, we produced thick and rigid films. To prevent their dissolution and reduce their swelling when in contact with aqueous solutions, we investigated a film neutralization step and characterized the mechanical and physical properties of the resulting films. On these neutralized chitosan films, we compared two micropatterning methods, i.e., hot embossing and mechanical micro-drilling, based on the resolution of microchannels from 100 µm to 1000 µm wide. Then, chitosan films with micro-drilled channels were bonded using a biocompatible dry photoresist on a glass slide or another neutralized chitosan film. Thanks to this protocol, the first functional chitosan microfluidic devices were prepared. While some steps of the fabrication process remain to be improved, these preliminary results pave the way toward a sustainable fabrication of lab-on-a-chip.

Indexed as

biomaterialschitosanhot embossinglab-on-a-chipmicro-drillingmicrofluidic

Identifiers

PMID38542626
PMCPMC10971945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.